Overview

Financials

News Discussions Technicals Forecast Seasonals

BIAF fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

‪9.02 M‬USD

—

−0.72USD

2014

Maria Zannes

bioaffinitytech.com

About

bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.

Ownership

‪‪28.46 M‬‬

Free Float shares

‪‪20.60 M‬‬ (72.39%)

Closely held shares

‪‪7.86 M‬‬ (27.61%)

Free Float shares

‪‪20.60 M‬‬ (72.39%)

Closely held shares

‪‪7.86 M‬‬ (27.61%)

Capital structure

Market cap

‪‪9.02 M‬‬

Debt

‪‪1.33 M‬‬

Cash & equivalents

‪‪444.71 K‬‬

Enterprise value

‪‪9.91 M‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary

‪‪9.02 M‬‬

Price to earning ratio (P/E)

—

Price to sales ratio (P/S)

0.60x

Market Cap

Net income

Revenue

Price to earning ratio (P/E)

—

Price to sales ratio (P/S)

0.60x

Valuation ratios

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q1 '25

‪0.00‬

‪1.10‬

‪2.20‬

‪3.30‬

‪4.40‬

P/S

Growth and Profitability

Company’s recent performance and margins

Performance

‪−144%‬

‪−128%‬

‪−112%‬

‪−96%‬

‪−80%‬

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q1 '25

‪‪−3.00 M‬‬

‪‪−1.50 M‬‬

‪0.00‬

‪‪1.50 M‬‬

‪‪3.00 M‬‬

Revenue

Net income

Net margin %

Revenue to profit conversion

Revenue

COGS

Gross profit

Op expenses

Op income

Non-Op income/ expenses

Taxes & Other

Net income

‪‪−3.00 M‬‬

‪‪−1.50 M‬‬

‪0.00‬

‪‪1.50 M‬‬

‪‪3.00 M‬‬

Revenue

COGS

Gross profit

Expenses & adjustments

Net income

‪‪−3.00 M‬‬

‪‪−1.50 M‬‬

‪0.00‬

‪‪1.50 M‬‬

‪‪3.00 M‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business

Period: 2024

Laboratory Services

Diagnostic Research and Development

By country

Period: 2024

United States

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue

Q2 '24

Q3 '24

Q4 '24

Q1 '25

Q2 '25

‪0.00‬

‪‪700.00 K‬‬

‪‪1.40 M‬‬

‪‪2.10 M‬‬

‪‪2.80 M‬‬

Actual

Estimate

Earnings

Next:Aug 19, 2025

Q2 '24

Q3 '24

Q4 '24

Q1 '25

Q2 '25

‪−0.20‬

‪−0.15‬

‪−0.10‬

‪−0.05‬

‪0.00‬

Actual

Estimate

Dividends

Dividend yield, history and sustainability

No dividends

BIAF has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company

Debt level and coverage

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q1 '25

‪‪−2.60 M‬‬

‪‪−1.30 M‬‬

‪0.00‬

‪‪1.30 M‬‬

‪‪2.60 M‬‬

Debt

Free cash flow

Cash & equivalents

Financial position analysis

Short term

Long term

‪0.00‬

‪‪1.00 M‬‬

‪‪2.00 M‬‬

‪‪3.00 M‬‬

‪‪4.00 M‬‬

Assets

Liabilities